- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06838390
Microcurrent Versus Transcutaneous Electrical Nerve Stimulation on Pressure Ulcer
Study Overview
Status
Conditions
Detailed Description
- Pressure sores are common problems in today's health care. A pressure sore leads to physiological as well as psychological suffering for the individual affected. The cost for the society, associated with prevention and treatment of pressure sores, is considerable
- Furthermore, the need for this study was developed from the lack of quantitative knowledge and information in the published studies about the effect of microcurrent and transcutaneous electrical nerve stimulation in treating pressure ulcers in elderly patients.
- This study will be carried out to provide guidelines about the effectiveness of microcurrent and transcutaneous electrical nerve stimulation in treating pressure ulcer and to assist in planning an ideal treatment regimen to increase healing of pressure ulcers in elderly patients.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cairo, Egypt
- out-patient clinic, faculty of physical therapy, Cairo university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Subject selection was done according to the following criteria:
- Age range between 40 and 60 years.
- Male and female patients will participate in the study.
- All patients enrolled in the study had their informed consent.
- Pressure ulcer grades were grade II and III.
- A relative or legal tutor provided consent when participants were incapable of making decisions.
- The trial complied with the ethical principles of the Helsinki Declaration for medical research in humans.
- Pressure ulcers were located in the sacral area
Exclusion Criteria:
- Age less than 40 years or more than 60 years
- A cardiac pacemaker or another implanted electric device.
- Cognitive problems or hearing loss.
- Pre-existing joint disorder before pressure ulcer.
- Patients who have co-morbidities such as diabetes mellitus, rheumatoid arthritis, hypertension, and cardiac and renal patients,
- Osteosynthesis implants near the ulcer, pressure ulcers in the occipital region, cancer, and osteomyelitis.
- Abnormal blood markers at baseline indicating limited healing potential (anemia, iron deficit, protein deficit, dehydration, non-controlled diabetes, or hypothyroidism).
- Allergy to the usual treatment for ulcer healing, systemic infection, and ulcer treatment with growth factor or vacuum-assisted closure in the 30 days before the Trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Microcurrent therapy
This group included 22 patients with pressure ulcer who received microcurrent therapy 8 weeks (3times /daily) in addition to their physical therapy program (circulatory exercise,stretching exercise, and ROM ex.) and medical treatment
|
The study uses a four-channel microcurrent therapy device to treat pressure ulcers.
The treatment involves applying four electrodes to the area around the ulcer, ensuring microcurrent passage throughout the wound bed.
The treatment is done three times a day, lasting 35-40 minutes.
The microcurrents are delivered in a monophasic, pulsed, square-form wave pulse with a voltage of 21 mV, an intensity of 42 µA, and a current density of 4.2 µA/cm.
The physiotherapy program included circulatory circulatory exercises, stretching exercises, and ROM exercises.
patients was given their drugs from their physicians
|
|
Active Comparator: transcutaneous electrical nerve stimulation
This group included 22 patients with pressure ulcers who received transcutaneous electrical nerve stimulation 8 weeks (3 times daily) in addition to their physical therapy program (circulatory exercise, stretching exercise, and range of motion exercise) and medical treatment.
|
The physiotherapy program included circulatory circulatory exercises, stretching exercises, and ROM exercises.
patients was given their drugs from their physicians
The study aimed to treat ulcers with TENS using a two-channel device, delivered three times a day, for 8 weeks.
The device induced peripheral vasodilation and activate local blood flow, potentially promoting wound healing.
The treatment was delivered using a pulse train duration of 300 ms, with an internal frequency of 100 Hz and a burst frequency of 2 Hz.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of ulcers length x width using Pressure Ulcer Scale for Healing
Time Frame: at baseline and after 8 weeks
|
The Pressure Ulcer Scale for Healing is a tool used to measure ulcer healing.
It assesses the length x width of the ulcer (measuring the greatest length-head to toe-and the greatest width-side to side-using a centimeter ruler).
It scores from 0-surface area of 0 cm²-to 10-surface area >24 cm²); The total score of pressure ulcer healing is calculated by adding three sub-scores, ranging from 0 (completely healed) to 17 (worst wound state), and comparing it at each time point indicates improvement or deterioration.
|
at baseline and after 8 weeks
|
|
Assessment of ulcers exudate amount using Pressure Ulcer Scale for Healing
Time Frame: at baseline and after 8 weeks
|
The Pressure Ulcer Scale for Healing is a tool used to measure ulcer healing.It assesses exudate amount (classified as none: score 0; light: score 1; moderate: score 2; or heavy: score 3); The total score of pressure ulcer healing is calculated by adding three sub-scores, ranging from 0 (completely healed) to 17 (worst wound state), and comparing it at each time point indicates improvement or deterioration.
|
at baseline and after 8 weeks
|
|
Assessment of ulcers tissue type using Pressure Ulcer Scale for Healing
Time Frame: at baseline and after 8 weeks
|
The Pressure Ulcer Scale for Healing is a tool used to measure ulcer healing. It assesses tissue type (score 1: superficial wound with epithelial tissue; score 2: the wound is clean and contains granulation tissue; score 3: there is any amount of slough present; score 4:necrotic tissue is present). If the wound is closed, the score is 0. The total score of pressure ulcer healing is calculated by adding three sub-scores, ranging from 0 (completely healed) to 17 (worst wound state), and comparing it at each time point indicates improvement or deterioration. |
at baseline and after 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of blood flow in both the major and the minor vessels of the body.
Time Frame: at baseline and after 8 weeks
|
Medical Doppler ultrasound is used in clinical adjustments to evaluate blood flow in major and minor vessels.
It shows normal and abnormal sign waveforms using spectral Doppler technique, which is individual to each vessel.
Understanding normal and abnormal diagnostics is crucial for operators and clinicians
|
at baseline and after 8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Hajar-005204
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.